3’-Beta-C-ethynyl-N6-iso-pentenyl adenosine
CAT:
804-HY-152453
Size:
Inquire
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

3’-Beta-C-ethynyl-N6-iso-pentenyl adenosine
- UNSPSC Description: 3’-Beta-C-ethynyl-N6-iso-pentenyl adenosine is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. Its popular products are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1]. 3’-Beta-C-ethynyl-N6-iso-pentenyl adenosine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
- Target Antigen: Nucleoside Antimetabolite/Analog
- Type: Oligonucleotides
- Related Pathways: Cell Cycle/DNA Damage
- Applications: Cancer-programmed cell death
- Field of Research: Cancer
- Assay Protocol: https://www.medchemexpress.com/3-beta-c-ethynyl-n6-iso-pentenyl-adenosine.html
- Solubility: 10 mM in DMSO
- Smiles: C/C(C)=C/CNC1=NC=NC2=C1N=CN2[C@H]3[C@H](O)[C@](O)(C#C)[C@@H](CO)O3
- Molecular Weight: 359.38
- References & Citations: [1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.|[2]Man S, et al. Potential and promising anticancer drugs from adenosine and its analogs. Drug Discov Today. 2021 Jun;26(6):1490-1500.
- Shipping Conditions: Room temperature
- Clinical Information: No Development Reported